Core Viewpoint - The article discusses the transformative impact of artificial intelligence (AI) on biotechnology, emphasizing the shift from experience-driven approaches to intelligent innovations in research and development [2]. Group 1: Event Overview - A cloud summit titled "AI-Driven: Decoding the Acceleration Code of Biotechnology Enterprises" will be held on May 27, 2025, featuring cross-disciplinary experts from AI and biotechnology [2]. - The summit aims to explore how to construct a closed-loop empowerment system between AI and experimental science, and how automation can serve as a research accelerator [2]. Group 2: Key Speakers and Topics - Guo Tiannan, a professor at Westlake University, will discuss building AI virtual cells using perturbation proteomics and active learning [6]. - Feng Xiaoping, from Zhizhu Huazhang Technology Co., will present industry exploration and outlook on AI for science [6]. - The session by Opentrons will focus on natural language-driven experimental design and the accessibility of automation [6]. - Li Xiangrong from DeepMind Technology will cover AI for science in the context of drug development [6]. Group 3: Technological Insights - The development of AI virtual cells (AIVC) relies on three key data pillars: prior knowledge, static architecture, and dynamic states, which are integrated through AI algorithms to simulate cellular behavior [18][20]. - AIVC aims to predict drug effects and analyze disease mechanisms by simulating real cellular processes, marking a significant advancement in biotechnology [20].
与西湖大学郭天南教授一起,探讨 AI 及自动化技术赋能科研,颠覆传统实验
生物世界·2025-05-23 03:16